NCT04883840View on ClinicalTrials.gov

Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

November 22, 2025

Study Completion Date

December 31, 2025

Conditions
Ulcerative Colitis
Interventions
DRUG

Rosuvastatin 10mg

Daily dose of one medication over 8 week period then switch to another medication over an 8 week period (type of medication during each intervention period is blinded and then randomized).

Trial Locations (2)

2820

NOT_YET_RECRUITING

Imelda Ziekenhuis, Bonheiden

3000

RECRUITING

UZ Leuven, Leuven

All Listed Sponsors
collaborator

Vlaams Instituut Biotechnologie (VIB)

UNKNOWN

lead

Universitaire Ziekenhuizen KU Leuven

OTHER